1. Clinical Overview
A fixed-dose combination (FDC) medication used primarily for the management of diabetic peripheral neuropathy (DPN). Epalrestat is an aldose reductase inhibitor (ARI) that reduces the accumulation of sorbitol in nerve cells, a key pathological factor in diabetic neuropathy. Methylcobalamin is an active form of Vitamin B12 that supports nerve regeneration, myelin synthesis, and neuronal function. This combination targets both the metabolic pathway causing nerve damage and provides nutritional support for nerve repair, making it a cornerstone therapy for symptomatic DPN in India.
| Onset | Duration | Bioavailability |
|---|---|---|
| Symptomatic relief may be observed within 4-8 weeks of continuous therapy, although biochemical effects of Epalrestat begin immediately. | Approximately 24 hours for Epalrestat. Methylcobalamin has a long tissue retention time, with effects sustained over weeks. | Epalrestat: ~80% (oral). Methylcobalamin: Variable, estimated 1-5% via oral route in intrinsic factor-dependent absorption; however, the 500mcg dose is supra-physiological to ensure adequate tissue levels. |
2. Mechanism of Action
The combination works via two complementary pathways. Epalrestat inhibits the enzyme aldose reductase in the polyol pathway. In hyperglycemia, excess glucose is shunted into this pathway, leading to accumulation of sorbitol and fructose within nerve cells, causing osmotic stress, depletion of myo-inositol, and reduced Na+/K+ ATPase activity, ultimately resulting in axonal degeneration and impaired nerve conduction velocity. By inhibiting aldose reductase, Epalrestat reduces sorbitol levels. Methylcobalamin acts as a coenzyme for methionine synthase, essential for the synthesis of methionine and S-adenosylmethionine (involved in phospholipid and myelin synthesis), and for L-methylmalonyl-CoA mutase, crucial for fatty acid metabolism in neurons. It promotes nerve regeneration, repairs damaged myelin sheaths, and improves neuronal function.
3. Indications & Uses
- Diabetic Peripheral Neuropathy (DPN) - for symptomatic management (pain, numbness, paresthesia) and improvement of nerve function.
- Prevention of progression of diabetic neuropathy.
4. Dosage & Administration
Adult Dosage: One tablet of Epalrestat 50mg + Methylcobalamin 500mcg, orally, three times a day (TID), preferably before meals.
Administration: Swallow the tablet whole with a glass of water. Take before meals to improve absorption consistency. Do not crush or chew. Therapy is long-term; consistent daily intake is crucial for efficacy.
5. Side Effects
Common side effects may include:
- Nausea
- Abdominal discomfort or pain
- Diarrhea
- Skin rash or itching
- Headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Chloramphenicol | May decrease the hematopoietic response to Methylcobalamin. | Moderate |
| Proton Pump Inhibitors (Omeprazole, Pantoprazole) | Long-term use may reduce absorption of dietary Vitamin B12; however, effect on pharmacological Methylcobalamin dose is likely minimal. | Low |
| Metformin | Long-term use may reduce serum Vitamin B12 levels. The high-dose Methylcobalamin in this FDC is intended to overcome this. | Low |
| Colchicine | May impair Vitamin B12 absorption. | Moderate |
| Antiepileptics (Phenytoin, Phenobarbital) | May reduce serum Methylcobalamin levels. | Moderate |
| Alcohol (Chronic use) | Can exacerbate neuropathy and may reduce the efficacy of therapy. | High |
7. Patient Counselling
- DO take the medicine regularly as prescribed, usually three times a day before meals.
- DO continue taking your anti-diabetic medications (insulin/oral drugs) as before. This medicine does not replace them.
- DO inform your doctor about all other medicines, vitamins, or supplements you are taking.
- DO attend regular follow-ups for blood sugar, kidney function, and liver tests.
- DONT stop the medicine abruptly without consulting your doctor, even if symptoms improve.
- DONT consume alcohol excessively as it can worsen neuropathy and liver health.
- DONT use this medicine for any condition other than prescribed.
8. Toxicology & Storage
Overdose: Acute overdose of Epalrestat may lead to severe gastrointestinal disturbances (nausea, vomiting, diarrhea), dizziness, and potential liver enzyme elevation. Methylcobalamin overdose is unlikely to cause acute toxicity due to its wide safety margin, but theoretically could lead to hypersensitivity.
Storage: Store below 30°C. Protect from light and moisture. Keep the container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack.